{"id":5762,"date":"2022-10-21T13:18:23","date_gmt":"2022-10-21T11:18:23","guid":{"rendered":"https:\/\/labradoodle.pl\/?page_id=5762"},"modified":"2022-11-29T09:32:20","modified_gmt":"2022-11-29T08:32:20","slug":"testy-zdrowotne","status":"publish","type":"page","link":"https:\/\/labradoodle.pl\/nl\/testy-zdrowotne\/","title":{"rendered":"Gezondheidstesten"},"content":{"rendered":"

[et_pb_section fb_built=\u201d1\u2033 admin_label=\u201dsection\u201d _builder_version=\u201d4.16\u2033 global_colors_info=\u201d{}\u201d][et_pb_row admin_label=\u201drow\u201d _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201dherhalen \u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.18.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

Gezondheidstesten<\/h1>\n

[\/et_pb_text][et_pb_text admin_label=\u201dText\u201d _builder_version=\u201d4.18.0\u2033 text_font=\u201d|300|||||||\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201dherhalen\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

Australian Labradoodle en gezondheidstesten. Dit zijn de ziekten waarop we onze honden testen:<\/h4>\n
<\/div>\n
Voornaamst:<\/strong><\/strong><\/div>\n
<\/strong><\/div>\n
\u2013 Heup- en elleboogdysplasie (FCI-normen)<\/div>\n
- Onjuiste vacht<\/div>\n
\u2013 Ziekte van Von Willebrand Type I, Type I vWD (VWF)
\u2013 Elliptocytose bij honden (SPTB Exon 30)
- Pyruvaatkinase-defici\u00ebntie (PKLR Exon 7, Labrador Retriever-variant)
\u2013 Progressieve retinale atrofie, prcd (PRCD Exon 1)
\u2013 Golden Retriever progressieve retinale atrofie 2, GR-PRA2 (TTC8)
\u2013 Progressieve retinale atrofie, crd4\/cord1 (RPGRIP1)
\u2013 Achromatopsie (CNGA3 Exon 7, Labrador Retriever-variant)
\u2013 Maculaire corneadystrofie, MCD (CHST6)
\u2013 Hyperuricosurie en hyperurikemie of urolithiasis, HUU (SLC2A9)
\u2013 Congenitale Keratoconjunctivitis Sicca en Ichthyosiforme Dermatose, Droge Ogen Krullende Vacht
\u2013 Syndroom, CKCSID (FAM83H Exon 5)
\u2013 GM2 gangliosidose (HEXB, poedelvariant)
\u2013 Ziekte van Alexander (GFAP)
\u2013 Degeneratieve Myelopathie, DM (SOD1A)
\u2013 Neonatale encefalopathie met epileptische aanvallen, NIEUWS (ATF2)
\u2013 Narcolepsie (HCRTR2 Intron 6, Labrador Retriever-variant)
\u2013 Spierdystrofie (DMD, Cavalier King Charles Spaniel Variant 1)
\u2013 Ullrich-achtige congenitale spierdystrofie (COL6A3 Exon 10, Labrador Retriever-variant)
\u2013 Centronucleaire Myopathie, CNM (PTPLA)
\u2013 Door inspanning ge\u00efnduceerde collaps, EIC (DNM1)
\u2013 Myotubulaire Myopathie 1, X-gebonden Myotubulaire Myopathie, XL-MTM (MTM1, Labrador Retriever
variant)<\/div>\n

[\/et_pb_text][dmg_masonry_gallery _builder_version=\u201d4.18.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][\/dmg_masonry_gallery][dmg_masonry_gallery gallery=\u201d4977,4975,4980\u2033 gutter=\u201d3\u2033 modal_title=\u201din_title\u201d hover_overlay_effect=\u201doverlay_image_data\u201d overlay_title_size=\u201d19px\u201d overlay_title_color=\u201d#FFFFFF\u201d show_overlay_caption=\u201duit\u201d overlay_caption_size=\u201d14px\u201d paginering_buttons_background=\u201dRGBA(255,255,255,0)\u201d paginering_buttons_background_active=\u201d#bcb 840\u2033 kolom s_tablet=\u201d2\u2033 columns_phone=\u201d2 \u2033 columns_last_edited=\u201dop|desktop\u201d _builder_version=\u201d4.18.0\u2033 _module_preset=\u201ddefault\u201d paginering_text_color=\u201d#bcb840\u2033 paginering_font_size=\u201d12px\u201d paginering_active_text_color=\u201d#71615b\u201d paginering_active_font_size=\u201d12px\u201d hover_enabled=\u201d 0\u2033 border_radii_image=\u201daan |12px | 12px | 12px | 12px "border_radi_pagination =" aan | 6px | 6px | 6px | 6px "border_radi_pagination_active =" aan | 6px | 6px | 6px | 6px "Box_shadow_style_pagination =" Preset1 \u2033 global_color thema_builder_area = "post_content" sticky_enabled =\u201d0 \u2033][\/dmg_masonry_gallery][et_pb_text _builder_version=\u201d4.18.0\u2033 _module_preset=\u201ddefault\u201d text_font=\u201d|300|||||||\u201d header_font=\u201d|300||||||||\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

De overige:<\/strong><\/div>\n
<\/div>\n
MDR1 Geneesmiddelgevoeligheid (ABCB1)<\/div>\n
P2Y12-receptorbloedplaatjesstoornis (P2Y12)<\/div>\n
Factor IX-tekort,<\/div>\n
Hemofilie B (F9 Exon 7, Terrier-variant) Factor IX-tekort,<\/div>\n
Hemofilie B (F9 Exon 7, Rhodesian Ridgeback-variant) Factor VII-defici\u00ebntie (F7 Exon 5) Factor VIII-defici\u00ebntie,<\/div>\n
Hemofilie A (F8 Exon 10, Boxer-variant) Factor VIII-defici\u00ebntie,<\/div>\n
Hemofilie A (F8 Exon 11, Duitse herder variant 1) Factor VIII-tekort, hemofilie A (F8 Exon 1, Duitse herder variant 2)<\/div>\n
Trombopathie (RASGRP1 Exon 5, Basset Hound-variant)<\/div>\n
Trombopathie (RASGRP1 Exon 8, Landseer-variant)<\/div>\n
Trombopathie (RASGRP1 Exon 5, Amerikaanse Eskimohond-variant)<\/div>\n
Ziekte van Von Willebrand Type III, Type III vWD (VWF Exon 4, Terrier Variant)<\/div>\n
Ziekte van Von Willebrand Type III, Type III vWD (VWF Exon 7, Shetland Sheepdog Variant)<\/div>\n
Ziekte van Von Willebrand Type II, Type II vWD (VWF, Pointer-variant)<\/div>\n
Canine Leukocyte Adhesie Defici\u00ebntie Type I,<\/div>\n
CLAD I (ITGB2, Setter Variant) Canine Leukocyte Adhesion Deficiency Type III,<\/div>\n
CLAD III (FERMT3, variant Duitse herder)<\/div>\n
Congenitale macrotrombocytopenie (TUBB1 Exon 1, Cairn en Norfolk Terrier-variant)<\/div>\n
Glanzmann's Thrombasthenia Type I (ITGA2B Exon 13, variant van de Grote Pyrenee\u00ebn)<\/div>\n
Glanzmann's Thrombasthenia Type I (ITGA2B Exon 12, Otterhound-variant)<\/div>\n
May-Hegglin-afwijkingen (MYH9)<\/div>\n
Aanvullende voorwaarden getest Prekallikre\u00efne-defici\u00ebntie (KLKB1 Exon 8)<\/div>\n
Pyruvaatkinasedefici\u00ebntie (PKLR Exon 5, Basenji-variant)<\/div>\n
Pyruvaatkinasedefici\u00ebntie (PKLR Exon 7, Pug-variant)<\/div>\n
Pyruvaatkinasedefici\u00ebntie (PKLR Exon 7, Beagle-variant)<\/div>\n
Pyruvaatkinasedefici\u00ebntie (PKLR Exon 10, Terrier-variant)<\/div>\n
Gevangen neutrofielensyndroom,<\/div>\n
TNS (VPS13B) Houtachtige membranenitis,<\/div>\n
LM (PLG) bloedplaatjesfactor X-receptordefici\u00ebntie,<\/div>\n
Scott-syndroom (TMEM16F)<\/div>\n
Methemoglobinemie (CYB5R3)<\/div>\n
Congenitale hypothyreo\u00efdie (TPO, Tenterfield Terrier-variant)<\/div>\n
Congenitale hypothyreo\u00efdie (TPO, Rat, Toy, Hairless Terrier-variant)<\/div>\n
Complement 3 Defici\u00ebntie,<\/div>\n
C3-defici\u00ebntie (C3) Ernstige gecombineerde immunodefici\u00ebntie,<\/div>\n
SCID (PRKDC, Terrier-variant) Ernstige gecombineerde immunodefici\u00ebntie,<\/div>\n
SCID (RAG1, Wetterhoun-variant) X-gebonden ernstige gecombineerde immunodefici\u00ebntie,<\/div>\n
X-SCID (IL2RG Exon 1, Basset Hound-variant)<\/div>\n
X-gebonden ernstige gecombineerde immunodefici\u00ebntie,<\/div>\n
X-SCID (IL2RG, Corgi-variant)<\/div>\n
Progressieve retinale atrofie, rcd1 (PDE6B Exon 21, Ierse Setter-variant)<\/div>\n
Progressieve retinale atrofie, rcd3 (PDE6A)<\/div>\n
Progressieve retinale atrofie, CNGA (CNGA1 Exon 9)<\/div>\n
Progressieve retinale atrofie, PRA1 (CNGB1)<\/div>\n
Aanvullende voorwaarden Getest Progressieve Retina Atrofie (SAG)<\/div>\n
Golden Retriever progressieve netvliesatrofie 1,<\/div>\n
GR-PRA1 (SLC4A3) Progressieve retinale atrofie,<\/div>\n
crd1 (PDE6B, Amerikaanse Staffordshireterri\u00ebr-variant)<\/div>\n
X-gekoppelde progressieve retinale atrofie 1,<\/div>\n
XL-PRA1 (RPGR) progressieve retinale atrofie,<\/div>\n
PRA3 (FAM161A) Collie-oogafwijkingen,<\/div>\n
choro\u00efdale hypoplasie,<\/div>\n
CEA (NHEJ1) Dagblindheid,<\/div>\n
kegel degeneratie,<\/div>\n
Achromatopsie (CNGB3 Exon 6, Duitse kortharige wijzervariant)<\/div>\n
Achromatopsie (CNGA3 Exon 7, variant Duitse herder)<\/div>\n
Autosomaal dominante progressieve retinale atrofie (RHO)<\/div>\n
Multifocale retinopathie bij honden, cmr1 (BEST1 Exon 2)<\/div>\n
Multifocale retinopathie bij honden, cmr2 (BEST1 Exon 5, Coton de Tulear-variant)<\/div>\n
Multifocale retinopathie bij honden, cmr3 (BEST1 Exon 10 deletie,<\/div>\n
Finse en Zweedse Lappenhond, Lapse Herder Variant)<\/div>\n
Glaucoom primaire open hoek (ADAMTS10 Exon 9, Noorse Elkhound-variant)<\/div>\n
Glaucoom primaire open hoek (ADAMTS10 Exon 17, Beagle-variant)<\/div>\n
Glaucoom primaire open hoek (ADAMTS17 Exon 11, Basset Fauve de Bretagne-variant)<\/div>\n
Primair openhoekglaucoom en primaire lensluxatie (ADAMTS17 Exon 2, Chinese Shar-Pei-variant)<\/div>\n
Goniodysgenese en glaucoom,<\/div>\n
Pectinate Ligament Dysplasie,<\/div>\n
PLD (OLFM3) Erfelijke staar,<\/div>\n
staar met vroege aanvang,<\/div>\n
Jeugdstaar (HSF4 Exon 9, Australian Shepherd-variant)<\/div>\n
Primaire lensluxatie (ADAMTS17)<\/div>\n
Aangeboren stationaire nachtblindheid (RPE65, Briard-variant)<\/div>\n
Aanvullende voorwaarden Getest Congenitale stationaire nachtblindheid (LRIT3, Beagle-variant)<\/div>\n
2,8-Dihydroxyadenine Urolithiasis,<\/div>\n
2,8-DHA Urolithiasis (APRT) Cystinurie Type IA (SLC3A1, Newfoundland-variant)<\/div>\n
Cystinurie Type II-A (SLC3A1, Australian Cattle Dog-variant)<\/div>\n
Cystinurie type II-B (SLC7A9, Dwergpinscher-variant)<\/div>\n
Polycysteuze nierziekte,<\/div>\n
PKD (PKD1) Primaire hyperoxalurie<\/div>\n
(AGXT) Eiwitverliezende nefropathie,<\/div>\n
PLN (NPHS1) X-gebonden erfelijke nefropathie,<\/div>\n
XLHN (COL4A5 Exon 35, Samojeed Variant 2)<\/div>\n
Autosomaal recessieve erfelijke nefropathie,<\/div>\n
familiale nefropathie,<\/div>\n
ARHN (COL4A4 Exon 3, Cocker Spaniel-variant)<\/div>\n
Primaire ciliaire dyskinesie, PCD (CCDC39 Exon 3, Old English Sheepdog-variant)<\/div>\n
Primaire ciliaire dyskinesie, PCD (NME5, Alaskan Malamute-variant)<\/div>\n
X-gebonden ectodermale dysplasie,<\/div>\n
Anhidrotische ectodermale dysplasie,<\/div>\n
XHED (EDA Intron 8) niercystadenocarcinoom en nodulaire dermatofibrose,<\/div>\n
RCND (FLCN Exon 7)<\/div>\n
Canine Fucosidose (FUCA1) Glycogeenstapelingsziekte Type II,<\/div>\n
ziekte van Pompe,<\/div>\n
GSD II (GAA, Finse en Zweedse Lappenhond, Lapse Herder Variant)<\/div>\n
Glycogeenstapelingsziekte Type IA,<\/div>\n
Von Gierke-ziekte,<\/div>\n
GSD IA (G6PC, Maltese variant)<\/div>\n
Glycogeenstapelingsziekte Type IIIA,<\/div>\n
GSD IIIA (AGL, Curly Coated Retriever-variant)<\/div>\n
Mucopolysaccharidose Type IIIA,<\/div>\n
Sanfilippo-syndroom Type A,<\/div>\n
MPS IIIA (SGSH Exon 6, teckelvariant) Mucopolysaccharidose type IIIA,<\/div>\n
Sanfilippo-syndroom Type A,<\/div>\n
MPS IIIA (SGSH Exon 6, Nieuw-Zeelandse Huntaway-variant)<\/div>\n
Aanvullende voorwaarden Getest Mucopolysaccharidose Type VII,<\/div>\n
Sly-syndroom,<\/div>\n
MPS VII (GUSB Exon 5, Terrier Brasileiro-variant)<\/div>\n
Mucopolysaccharidose Type VII,<\/div>\n
Sly-syndroom,<\/div>\n
MPS VII (GUSB Exon 3, variant Duitse herder)<\/div>\n
Glycogeenstapelingsziekte Type VII,<\/div>\n
Fosfofructokinase-defici\u00ebntie,<\/div>\n
PFK-defici\u00ebntie (PFKM, Whippet en Engelse springerspani\u00ebl-variant)<\/div>\n
Glycogeenstapelingsziekte Type VII,<\/div>\n
Fosfofructokinase-defici\u00ebntie,<\/div>\n
PFK-tekort (PFKM, Wachtelhund-variant)<\/div>\n
Lagotto-stapelingsziekte (ATG4D)<\/div>\n
Neuronale Ceroid Lipofuscinose 1, NCL 1 (PPT1 Exon 8, Teckel Variant 1)<\/div>\n
Neuronale Ceroid Lipofuscinose 2, NCL 2 (TPP1 Exon 4, Teckel Variant 2)<\/div>\n
Neuronale Ceroid Lipofuscinose,<\/div>\n
Cerebellaire ataxie, NCL4A (ARSG Exon 2, American Staffordshire Terrier-variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 5, NCL 5 (CLN5 Exon 4 SNP, Border Collie Variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 6, NCL 6 (CLN6 Exon 7, Australian Shepherd Variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 8, NCL 8 (CLN8 Exon 2, Engelse Setter-variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 7, NCL 7 (MFSD8, Chihuahua en Chinese Crested Variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 8, NCL 8 (CLN8, Australian Shepherd Variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 10, NCL 10 (CTSD Exon 5, American Bulldog-variant)<\/div>\n
Neuronale Ceroid Lipofuscinose 5, NCL 5 (CLN5 Exon 4-deletie, Golden Retriever-variant)<\/div>\n
Neuronale Ceroid Lipofuscinose met aanvang op volwassen leeftijd, NCL A, NCL 12 (ATP13A2, Tibetaanse Terri\u00ebr-variant)<\/div>\n
Neuronale ceroid lipofuscinose met late aanvang, NCL 12 (ATP13A2, Australian Cattle Dog-variant)<\/div>\n
GM1 gangliosidose (GLB1 Exon 15, Shiba Inu-variant)<\/div>\n
GM1 gangliosidose (GLB1 Exon 15, Alaskan Husky-variant)<\/div>\n
GM1 gangliosidose (GLB1 Exon 2, Portugese waterhond variant) Aanvullende voorwaarden getest<\/div>\n
GM2 gangliosidose (HEXA, Japanse kinvariant)<\/div>\n
Globo\u00efde celleukodystrofie,<\/div>\n
Ziekte van Krabbe (GALC Exon 5, Terrier-variant)<\/div>\n
Autosomaal Recessieve Amelogenesis Imperfecta,<\/div>\n
Familiale glazuurhypoplasie (ENAM-deletie, Italiaanse windhondvariant)<\/div>\n
Autosomaal Recessieve Amelogenesis Imperfecta,<\/div>\n
Familiale glazuurhypoplasie (ENAM SNP, Parson Russell Terrier-variant)<\/div>\n
Aanhoudend Mullerian Duct-syndroom,<\/div>\n
PMDS (AMHR2) Doofheid en vestibulair syndroom van Dobermans,<\/div>\n
DVDob, DINGS (MYO7A) Auto-inflammatoire ziekte van Shar-Pei,<\/div>\n
SPAID,<\/div>\n
Shar Pei-koorts (MTBP)<\/div>\n
Neonatale interstiti\u00eble longziekte (LAMP3)<\/div>\n
Alaskan Husky-encefalopathie,<\/div>\n
Subacute necrotiserende encefalomyelopathie (SLC19A3)<\/div>\n
Cerebella Abiotrofie,<\/div>\n
Neonatale cerebellaire corticale degeneratie,<\/div>\n
NCCD (SPTBN2, Beagle-variant)<\/div>\n
cerebellaire ataxie,<\/div>\n
Progressieve cerebellaire ataxie met vroege aanvang (SEL1L, variant van de Finse hond)<\/div>\n
Cerebellaire hypoplasie (VLDLR, Eurasier-variant)<\/div>\n
spinocerebellaire ataxie,<\/div>\n
Ataxie met late aanvang,<\/div>\n
LoSCA (CAPN1)<\/div>\n
Spinocerebellaire ataxie met myokymie en\/of convulsies (KCNJ10)<\/div>\n
erfelijke ataxie,<\/div>\n
Cerebellaire degeneratie (RAB24, Old English Sheepdog en Gordon Setter Variant)<\/div>\n
Goedaardige familie jeugdepilepsie,<\/div>\n
Remitting Focale Epilepsie (LGI2)<\/div>\n
Foetaal begin neonatale neuroaxonale dystrofie (MFN2, Riesenschnauzer-variant)<\/div>\n
Hypomyelinisatie en trillingen (FNIP2, Weimaraner-variant)<\/div>\n
Shaking Puppy-syndroom,<\/div>\n
X-gebonden gegeneraliseerd tremorsyndroom (PLP1, variant Engelse springerspani\u00ebl)<\/div>\n
neuroaxonale dystrofie,<\/div>\n
NAD (TECPR2, variant Spaanse waterhond)<\/div>\n
Aanvullende voorwaarden Getest Neuroaxonale dystrofie,<\/div>\n
NAD (VPS11, Rottweiler-variant)<\/div>\n
L-2-Hydroxyglutaricacidurie,<\/div>\n
L2HGA (L2HGDH,<\/div>\n
Staffordshire Bull Terrier-variant)<\/div>\n
Alaskan Malamute polyneuropathie,<\/div>\n
AMPN (NDRG1 SNP)<\/div>\n
Narcolepsie (HCRTR2 Exon 1, teckelvariant)<\/div>\n
Progressieve neuronale abiotrofie,<\/div>\n
Honds meervoudige systeemdegeneratie,<\/div>\n
CMSD (SERAC1 Exon 15, Kerry Blue Terrier-variant)<\/div>\n
Progressieve neuronale abiotrofie,<\/div>\n
Honds meervoudige systeemdegeneratie,<\/div>\n
CMSD (SERAC1 Exon 4, Chinese Naakthondvariant)<\/div>\n
Juveniele larynxverlamming en polyneuropathie,<\/div>\n
Polyneuropathie met oculaire afwijkingen en neuronale vacuolatie,<\/div>\n
POANV (RAB3GAP1, Rottweiler-variant)<\/div>\n
erfelijke sensorische autonome neuropathie,<\/div>\n
Acral Mutilatie Syndroom,<\/div>\n
AMS (GDNF-AS, Spaniel en Pointer-variant)<\/div>\n
Sensorische neuropathie (FAM134B, Border Collie-variant)<\/div>\n
Polyneuropathie met juveniele aanvang,<\/div>\n
Leonberger polyneuropathie 1,<\/div>\n
LPN1 (LPN1, ARHGEF10)<\/div>\n
Juveniele myoclonische epilepsie (DIRAS1)<\/div>\n
Polyneuropathie met juveniele aanvang,<\/div>\n
Leonberger polyneuropathie 2,<\/div>\n
LPN2 (GJA9) Sponsachtige degeneratie met cerebellaire ataxie 1,<\/div>\n
SDCA1,<\/div>\n
SeSAME\/EAST-syndroom (KCNJ10)<\/div>\n
Sponsachtige degeneratie met cerebellaire ataxie 2,<\/div>\n
SDCA2 (ATP1B2) Gedilateerde cardiomyopathie,<\/div>\n
DCM1 (PDK4, Doberman Pinscher variant 1)<\/div>\n
gedilateerde cardiomyopathie,<\/div>\n
DCM2 (TTN, Dobermann Pinscher variant 2)<\/div>\n
Lang QT-syndroom (KCNQ1)<\/div>\n
Cardiomyopathie en jeugdsterfte (YARS2)<\/div>\n
Spierdystrofie (DMD, Golden Retriever-variant)<\/div>\n
Ledematengordel spierdystrofie (SGCD, Boston Terrier-variant)<\/div>\n
Aanvullende aandoeningen Getest Erfelijke myopathie van Duitse doggen (BIN1)<\/div>\n
Myostatine-tekort,<\/div>\n
Bully Whippet-syndroom (MSTN)<\/div>\n
Myotonia Congenita (CLCN1 Exon 7, Dwergschnauzer-variant)<\/div>\n
Myotonia Congenita (CLCN1 Exon 23, Australian Cattle Dog-variant)<\/div>\n
Inflammatoire myopathie (SLC25A12) Hypocatalasie,<\/div>\n
Acatalasemie (CAT)<\/div>\n
Pyruvaatdehydrogenasedefici\u00ebntie (PDP1, spani\u00eblvariant)<\/div>\n
Kwaadaardige hyperthermie (RYR1)<\/div>\n
Imerslund-Grasbeck-syndroom,<\/div>\n
Selectieve cobalamine-malabsorptie (CUBN Exon 53, Border Collie-variant)<\/div>\n
Imerslund-Grasbeck-syndroom,<\/div>\n
Selectieve malabsorptie van cobalamine (CUBN Exon 8, Beagle-variant)<\/div>\n
Erfelijke geselecteerde cobalaminemalabsorptie met prote\u00efnurie (CUBN, Komondor-variant)<\/div>\n
Lundehund-syndroom (LEPREL1)<\/div>\n
Congenitaal myasthenisch syndroom,<\/div>\n
CMS (CHAT, Oud-Deense Staande Hond Variant)<\/div>\n
Congenitaal myasthenisch syndroom,<\/div>\n
CMS (CHRNE, Jack Russell Terrier-variant),<\/div>\n
CMS (COLQ, Golden Retriever-variant)<\/div>\n
Myasthenia Gravis-achtig syndroom (CHRNE, Heideterrier-variant)<\/div>\n
Paroxysmale dyskinesie,<\/div>\n
PxD (VARKEN)<\/div>\n
Demyeliniserende polyneuropathie (SBF2\/MTRM13)<\/div>\n
Dystrofische epidermolyse bullosa (COL7A1, Golden Retriever-variant)<\/div>\n
Dystrofische epidermolysis bullosa (COL7A1, Centraal-Aziatische herdershondvariant)<\/div>\n
Aanvullende voorwaarden Getest Ectodermale dysplasie,<\/div>\n
Huidfragiliteitssyndroom (PKP1, Chesapeake Bay Retriever-variant) Ichthyosis,<\/div>\n
Epidermolytische hyperkeratose (KRT10, Terrier-variant)<\/div>\n
Ichthyosis ICH1 (PNPLA1, Golden Retriever-variant)<\/div>\n
Ichthyosis (SLC27A4, Duitse dog-variant)<\/div>\n
Ichthyosis (NIPAL4, American Bulldog-variant)<\/div>\n
Erfelijke Voetzool Hyperkeratose (FAM83G, Terrier en Kromfohrlander Variant)<\/div>\n
Erfelijke Voetzool Hyperkeratose (DSG1, Rottweiler Variant)<\/div>\n
Musladin-Lueke-syndroom,<\/div>\n
MLS (ADAMTSL2) Oculocutaan albinisme,<\/div>\n
OCA (SLC45A2, variant voor kleine rassen)<\/div>\n
Kale dij syndroom (IGFBP5)<\/div>\n
dodelijke acrodermatitis,<\/div>\n
LAD (MKLN1)<\/div>\n
Ehlers Danlos (ADAMTS2, Doberman Pinscher-variant)<\/div>\n
Gespleten lip en\/of gespleten gehemelte (ADAMTS20, Nova Scotia Duck Tolling Retriever-variant)<\/div>\n
Erfelijke vitamine D-resistente Ricketts (VDR) Osteogenesis Imperfecta,<\/div>\n
\n
Brozebottenziekte (COL1A2, Beagle-variant) Osteogenesis Imperfecta,<\/div>\n
Brozebottenziekte (SERPINH1, teckelvariant)<\/div>\n
Osteogenese Imperfecta,<\/div>\n
Brozebottenziekte (COL1A1, Golden Retriever-variant)<\/div>\n
Craniomandibulaire osteopathie,<\/div>\n
CMO (SLC37A2) Raine-syndroom,<\/div>\n
Canine Dental Hypomineralisatie Syndroom (FAM20C)<\/div>\n
Chondrodystrofie (ITGA10,<\/div>\n
Noorse Elkhound en Karelische Berenhond Variant)<\/div>\n<\/div>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

GezondheidstestenAustralische Labradoodle en gezondheidstesten. Dit zijn de ziekten waarop we onze honden testen: Belangrijkste ziekten: \u2013 Heup- en elleboogdysplasie (FCI-normen) \u2013 Onjuiste vacht \u2013 Ziekte van Von Willebrand Type I, Type I vWD (VWF) \u2013 Canine Elliptocytose (SPTB Exon 30) \u2013 Pyruvaatkinasedefici\u00ebntie (PKLR) Exon 7, Labrador Retriever Variant) - Progressieve retinale atrofie, prcd (PRCD Exon [\u2026]<\/p>","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-5762","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/pages\/5762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/comments?post=5762"}],"version-history":[{"count":6,"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/pages\/5762\/revisions"}],"predecessor-version":[{"id":5845,"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/pages\/5762\/revisions\/5845"}],"wp:attachment":[{"href":"https:\/\/labradoodle.pl\/nl\/wp-json\/wp\/v2\/media?parent=5762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}